InspireMD
NSPR
0 hedge funds and large institutions have $23.4M invested in InspireMD in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
28% less capital invested
Capital invested by funds: $32.7M → $23.4M (-$9.26M)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$15.5M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$1.69M |
| 3 |
OC
Oppenheimer & Co
New York
|
-$53K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OC
26
Oppenheimer & Co
New York
| – | -$53K | – | – |
|
|
27
Wells Fargo
San Francisco,
California
| – | -$6K | – | – |
|
NSPR Hedge Fund Activity: Q3 2014 in Review
0 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q3 2014, worth a combined $23.4M — down 28% from $32.7M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NSPR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was OrbiMed, exiting entirely with an estimated $15.5M sold.
- 0 institutional investors held InspireMD (NSPR) as of Q3 2014, down from 1 in Q2 2014.
- Funds reported $23.4M of InspireMD stock for Q3 2014, down 28% quarter-over-quarter.
- 0 funds opened new InspireMD positions in Q3 2014 and 1 closed out, a net change of -1 holder.
- The largest InspireMD seller in Q3 2014 was OrbiMed, an estimated $15.5M sold.
Based on aggregated 13F filings for Q3 2014.